Silver Book Fact

Early Gene Therapy Studies Show Promise for Parkinson’s Disease

Fact image

Lopes J. AXO-Lenti-PD Gene Therapy Shows Benefits in 2 Advanced Parkinson’s Patients in Phase 1/2 Trial. Parkinson's News Today. March 14 2019. https://parkinsonsnewstoday.com/2019/03/14/axo-lenti-pd-gene-therapy-shows-benefits-2-patients-phase-1-2-trial/. Accessed June 11, 2019

Christine C, Bankiewicz K, Van Laar A, Richardson R, et al. Magnetic Resonance Imaging-Guided Phase 1 Trial of Putanimal AADC Gene Therapy for Parkinson’s Disease. Ann Neurol. 2019; 85(5). https://www.onlinelibrary.wiley.com/doi/10.1002/ana.25450

Reference

Title
AXO-Lenti-PD Gene Therapy Shows Benefits in 2 Advanced Parkinson’s Patients in Phase 1/2 Trial
Publication
Parkinson's News Today
Publication Date
March 14 2019
Authors
Lopes J
URL
Read Full Resource
Title
Magnetic Resonance Imaging-Guided Phase 1 Trial of Putanimal AADC Gene Therapy for Parkinson’s Disease
Publication
Ann Neurol
Publication Date
2019
Authors
Christine C, Bankiewicz K, Van Laar A, Richardson R, et al.
Volume & Issue
Volume 85, Issue 5
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Deep Brain Stimulation for Parkinson’s Adds QALYs and Saves Money
     
  • An Alzheimer’s disease research study showed that billions of dollars could be saved if physicians could intervene before someone becomes symptomatic. This positive net savings occurred with both drug treatment…  
  • The U.S. Food and Drug Administration has approved 5 drugs that have proven to temporarily slow the worsening of Alzheimer’s disease symptoms for an average of 6 – 12 months…  
  • Americans Age 65 and Older with Alzheimer’s Disease, 2010–2050  
  • Current research supported by the National Institute of Neurological Disease Orders and Stroke (NINDS) at NIH is using animal models to study progression of the disease and develop new drugs…